
1. j acad dermatol. 1990 jun;22(6 pt 2):1210-7.

langerhans cells hiv-1 infection.

stingl g(1), rappersberger k, tschachler e, gartner s, groh v, mann dl, wolff k, 
popovic m.

author information: 
(1)department dermatology i, university vienna medical school, austria.

the skin-specific immune surveillance system protects invading
microorganisms transformed cells expressing tumor-specific neoantigens. 
system includes antigen-presenting langerhans cells, dermal epidermal t
lymphocytes, cytokine-producing keratinocytes, draining peripheral lymph
nodes. patients infected human immunodeficiency virus-1 (hiv-1), this
surveillance system appears compromised, evidenced reduction the
epidermal langerhans cell population. human epidermal langerhans cell
express surface-bound cd4 antigens, hla-dr antigens, fc-igg receptors, of
which involved hiv-1 binding to, entry into, target cell, the
reduction langerhans cells patients acquired immunodeficiency syndrome
(aids) aids-related complex (arc) may direct consequence hiv-1
infection subsequent injury langerhans cells. detailed ultrastructural
studies confirmed moderate severe morphologic damage langerhans
cells patients presence hiv-1-like particles langerhans
cell surface membranes extracellular spaces. biologic consequences
of langerhans cell infection hiv-1 could either impaired antigen
presentation function viable langerhans cells possible transmission 
retrovirus t-cell compartment skin lymph nodes, subsequent
depletion cd4+ cells via widespread syncytia formation between
hiv-1-infected noninfected cells. facts herpes simplex virus,
specific cytokines, ultraviolet b radiation activate signals hiv-1
expression epidermal cells elaborate large amounts cytokines,
particularly enhanced ultraviolet b exposure, may important clinical
implications hiv-1-infected patients.

doi: 10.1016/0190-9622(90)70165-e 
pmid: 2193948  [indexed medline]

